Proteomic analysis of the MCF7 breast cancer cell line

Cancer Genomics and Proteomics

Volumn 3, Issue 6, 2006, Pages 355-368

  Hardouin, Julie ^a   Canelle, Ludovic ^a   Vlieghe, Céline ^a   Lasserre, Jean Paul ^a   Caron, Michel ^a   Joubert Caron, Raymonde ^a,b  

^a UNIVERSITÉ PARIS 13   (France)

^b UFR SMBH Léonard de Vinci   (France)

Author keywords

2 DE databases; Breast cancer; Mass spectrometry; MCF7 cell line; Proteome

Indexed keywords

ISOPROTEIN; POLYPEPTIDE;

AMINO ACID SEQUENCE; ARTICLE; BIOINFORMATICS; BREAST CANCER; CANCER CELL CULTURE; CELL STRAIN MCF 7; CONTROLLED STUDY; GROWTH CURVE; HUMAN; HUMAN CELL; IMAGE ANALYSIS; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS; UNINDEXED SEQUENCE;

EID: 33845970902     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Hortobagyi GN, de la Garza Salazar J, Pritchard K, Amadori D, Haidinger R, Hudis CA, Khaled H, Liu MC, Martin M, Namer M, O'Shaughnessy JA, Shen ZZ and Albain KS: The global breast cancer burden: variations in epidemiology and survival. Clin Breast Cancer 6: 391-401, 2005.
2. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ and Thun MJ: Cancer statistics, 2004. CA Cancer J Clin 54: 8-29, 2004.
3. Wang D, Jensen RH, Williams KE and Pallavicini MG: Differential protein expression in MCF7 breast cancer cells transfected with ErbB2, neomycin resistance and luciferase plus yellow fluorescent protein. Proteomics 4: 2175-2183, 2004.
4. Chopin V, Slomianny C, Hondermarck H and Le Bourhis X: Synergistic induction of apoptosis in breast cancer cells by cotreatment with butyrate and TNF-alpha, TRAIL, or anti-Fas agonist antibody involves enhancement of death receptors' signaling and requires P21(waf1). Exp Cell Res 298: 560-573, 2004.
5. Gehrmann ML, Fenselau C and Hathout Y: Highly altered protein expression profile in the adriamycin resistant MCF-7 cell line. J Proteome Res 3: 403-409, 2004.
6. Gehrmann ML, Hathout Y and Fenselau C: Evaluation of metabolic labeling for comparative proteomics in breast cancer cells. J Proteome Res 3: 1063-1068, 2004.
7. Hathout Y, Gehrmann ML, Chertov A and Fenselau C: Proteomic phenotyping: metastatic and invasive breast cancer. Cancer Lett 210: 245-253, 2004.
8. Englbrecht CC and Facius A: Bioinformatics challenges in proteomics. Comb Chem High Throughput Screen 8: 705-715, 2005.
9. Righetti PG, Castagna A, Antonucci F, Piubelli C, Cecconi D, Campostrini N, Zanusso G and Monaco S: The proteome: Anno Domini 2002. Clin Chem Lab Med 41: 425-438, 2003.
10. Thiede B, Hohenwarter W, Krah A, Mattow J, Schmid M, Schmidt F and Jungblut PR: Peptide mass fingerprinting. Methods 35: 237-247, 2005.
11. Gorg A, Weiss W and Dunn MJ: Current two-dimensional electrophoresis technology for proteomics. Proteomics 4: 3665-3685, 2004.
12. Pietrogrande MC, Marchetti N, Dondi F and Righetti PG: Decoding 2D-PAGE complex maps: Relevance to proteomics. J Chromatogr B Analyt Technol Biomed Life Sci 835: 51-62, 2006.
13. Hoogland C, Sanchez JC, Walther D, Baujard V, Baujard O, Tonella L, Hochstrasser DF and Appel RD: Two-dimensional electrophoresis resources available from ExPASy. Electrophoresis 20: 3568-3571, 1999.
14. Poirier F, Pontet M, Labas V, le Caer JP, Sghiouar-Imam N, Raphael M, Caron M and Joubert-Caron R: Two-dimensional database of a Burkitt lymphoma cell line (DG 75) proteins: protein pattern changes following treatment with 5′-azycytidine. Electrophoresis 22: 1867-1877, 2001.
15. Joubert-Caron R and Caron M: Proteome analysis in the study of lymphoma cells. Mass Spectrom Rev 24: 455-468, 2005.
16. Pionneau C, Canelle L, Bousquet J, Hardouin J, Bigeard J, Caron M and Joubert-Caron R: Proteomic analysis of membrane-associated proteins from the breast cancer cell line MCF7. Cancer Genom Proteom 2: 199-208, 2005.
17. Canelle L, Bousquet J, Pionneau C, Deneux L, Imam-Sghiouar N, Caron M and Joubert-Caron R: An efficient proteomics-based approach for the screening of autoantibodies. J Immunol Methods 299: 77-89, 2005.
18. Canelle L, Pionneau C, Marie A, Bousquet J, Bigeard J, Lutomski D, Kadri T, Caron M and Joubert-Caron R: Automating proteome analysis: improvements in throughput, quality and accuracy of protein identification by peptide mass fingerprinting. Rapid Commun Mass Spectrom 18: 2785-2794, 2004.
19. Caron M, Imam-Sghiouar N, Poirier F, Le Caer JP, Labas V and Joubert-Caron R: Proteomic map and database of lymphoblastoid proteins. J Chromatogr B Analyt Technol Biomed Life Sci 777: 197-209, 2002.
20. Al-Shahrour F, Minguez P, Vaquerizas JM, Conde L and Dopazo J: Babelomics: a suite of web-tools for functional annotation and analysis of group of genes in high-throughput experiments. Nucleic Acids Res (Web Server issue) 33: 460-464, 2005.